The compound verproside is a catalpol derivative with anti-inflammatory, antioxidant and antinociceptive activities [36] and is a potent anti-asthmatic/COPD drug candidate, acting by blocking the TNF-α/NF-κB signaling pathway [37,38]. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.